Repotrectinib
Merck wins FDA nod for pneumococcal vaccine; Roche partners Ascidian to develop novel gene therapies

Merck wins FDA nod for pneumococcal vaccine; Roche partners Ascidian to develop novel gene therapies

This week saw the US Food and Drug Administration (FDA) approve Merck’s next-generation pneumococcal vaccine for adults. ...

Impressions : 1518